The Cost of Diagnosis of Leprosy by Active Case Detection in Kailali, Nepal

Authors

  • Rabindra Baskota Ministry of Health and Population, Nepal https://orcid.org/0000-0002-3589-2921
  • Dinesh Rupakheti Department of Health Services, Teku, Nepal
  • Anjan Rai Nobel Medical College, Biratnagar,Nepal
  • Bikram Gyawali Devdaha Medical College and Research Institute, Lumbini, Nepal
  • Rashmi Baral Department of Drug Administration, Ministry of Health and Population, Nepal

DOI:

https://doi.org/10.3126/njdvl.v21i2.52239

Keywords:

Active case detection; Cost effectiveness; Early diagnosis; Leprosy

Abstract

Introduction: Leprosy is a is a chronic infectious disease caused by Mycobacterium leprae. Current modalities for early diagnosis of leprosy include active case detection campaigns, contact tracing, and skin camps. Active case detection is an effective strategy that enables early treatment, prevents impending disability, and potentially stops the spread of leprosy.

Objectives: This study was conducted to determine the cost of early diagnosis of leprosy by active case detection method in Lamkichuha Municipality of Kailali district.

Materials and Methods: In coordination with the Municipality, Leprosy Control and Disability Management Section of Ministry of Health and Population conducted a survey in July of 2022. Using active case detection method, orientation on leprosy was given to health workers followed by household visit and screening of skin lesions suggestive of leprosy. Suspected cases were confirmed by dermatologists. Data obtained from the campaign was analyzed and results presented as cost per patient.

Results: The team screened 4526 families that included 21472 persons in the Lamkichuha Municipality.  Among them, 195 were suspected as leprosy by the health workers and referred to referral health facility for diagnosis. Three of them were confirmed as leprosy resulting the prevalence rate of 1.4 per 10,000 populations. The average cost spent per patient was NRS 250000 (2000 USD).

Conclusion: The cost of diagnosis of leprosy by active case detection is high. The national programs should prioritize cost-effective modalities including the awareness raising campaigns for early diagnosis.

Downloads

Download data is not yet available.
Abstract
49
PDF
33

Author Biographies

Rabindra Baskota, Ministry of Health and Population, Nepal

Senior Consultant Dermatologist

Dinesh Rupakheti, Department of Health Services, Teku, Nepal

Consultant

Anjan Rai, Nobel Medical College, Biratnagar,Nepal

Lecturer

Bikram Gyawali, Devdaha Medical College and Research Institute, Lumbini, Nepal

Assistant Professor

Rashmi Baral, Department of Drug Administration, Ministry of Health and Population, Nepal

Chemist Officer

Downloads

Published

2023-10-02

How to Cite

Baskota, R., Rupakheti, D., Rai, A., Gyawali, B., & Baral, R. (2023). The Cost of Diagnosis of Leprosy by Active Case Detection in Kailali, Nepal. Nepal Journal of Dermatology, Venereology &Amp; Leprology, 21(2), 16–19. https://doi.org/10.3126/njdvl.v21i2.52239

Issue

Section

Original Articles